Drägerwerk stock: MWB Research keeps EUR 135.00 target for Drägerwerk stock

Published on 10/21/2026 at 17:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Safety orders rose 20.20 percent in third-quarter 2026. Drägerwerk stock costs EUR 96.90 on October 21, 2026, plus 2.54 percent versus the Xetra close.

MWB target and quarterly figures

MWB Research kept its EUR 135.00 target for Drägerwerk on October 9, 2026.
Safety Technology order intake rose 20.20 percent in the third quarter of 2026.
Drägerwerk stock costs EUR 96.90 at Lang & Schwarz on October 21, 2026 at 5:06 p.m. CEST, plus 2.54 percent versus the Xetra close of October 20, 2026.

Moderne Intensivstation mit Beatmungsgerät und Patientenmonitoring in klinischer Umgebung — Drägerwerk AG & Co. KGaA zeigt moderne Intensivstation mit Beatmungsgeräten und Patientenmonitoring DE0005550636, Illustration mit AI erstellt.

MWB Research kept its Buy rating and EUR 135.00 price target for Drägerwerk on October 9, 2026, according to MarketScreener. The target stands 39.22 percent above the EUR 96.90 price. At Lang & Schwarz, the stock was trading at EUR 96.90 on October 21, 2026 at 5:06 p.m. CEST, plus 2.54 percent versus the Xetra close of October 20, 2026 at EUR 94.50.

Safety orders lead quarterly growth

Drägerwerk's preliminary third-quarter figures showed a mixed operating picture. According to MarketScreener, revenue increased 2.10 percent to EUR 851 million in the third quarter of 2026, while EBIT fell to EUR 48 million from EUR 56.70 million in the third quarter of 2025. The EBIT figure included EUR 20.10 million in customs-duty refunds.

Safety Technology supplied the stronger demand signal. Its order intake rose 20.20 percent to EUR 452 million in the third quarter of 2026, compared with EUR 371.40 million a year earlier. Medical Technology order intake declined 3.00 percent to EUR 474 million from EUR 484.70 million.

Stock sits below its yearly high

The EUR 96.90 Lang & Schwarz price is 22.73 percent below the 52-week high of EUR 125.40 and above the 52-week low of EUR 66.00, both as of October 21, 2026. Market capitalization stood at EUR 1.8 billion, while the price-to-earnings ratio was 10.68 on the same date.

Forecast and next reporting date

Drägerwerk confirmed its 2026 outlook in the preliminary release dated October 14, 2026. The company continues to expect currency-adjusted revenue growth of 2.00 to 6.00 percent and an EBIT margin of 6.00 to 8.00 percent, according to FinanzNachrichten. The quarterly statement is scheduled for October 29, 2026.

For investors, the key contrast is clear: Safety Technology order intake grew 20.20 percent in the third quarter, but group EBIT margin was 5.60 percent against 6.80 percent a year earlier. The confirmed full-year margin range therefore remains materially above the latest quarterly level.

Price and target in context

MWB Research's EUR 135.00 target is 39.22 percent above the Lang & Schwarz price, calculated against EUR 96.90 on October 21, 2026. The stock remains 22.73 percent below its 52-week high of EUR 125.40.

The further course of trading is shown by the continuously updated real-time quote of Drägerwerk stock.